Exelixis, Inc. (EXEL)

43.96 -1.48 (-3.26%) USD  |  NASDAQ  |  Jan 16, 16:00
43.98 +0.02 (+0.05%) After-Hours: 20:00
More

Exelixis Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for EXEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Natera, Inc. Upgrade
Merck & Co., Inc. Upgrade